Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - RegeneRx Biopharmaceut. (OTC BB:RGRX.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | News | Profile | SEC
Location
3 Bethesda Metro Center, Suite 700
Bethesda, MD 20814
Phone: (301) 961-1992
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 51%
·Institutional: 1% (2% of float)
(3 institutions)
·Net Inst. Buying: 100.0K shares (+33.12%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
RegeneRx Biopharmaceuticals, Inc. is a pharmaceutical research and development company focusing on the development of products to treat a variety of human diseases. Historically, the Company's primary business focus was the commercialization of Thymosin alpha 1 (T(alpha)1), a 28-amino acid peptide shown to regulate the immune system in animal models. T(alpha)1 is now approved for the treatment of hepatitis b and c and as an immune adjuvant in 20 countries outside the United States, and is in registration for approval in several more. The Company's current primary business focus is the commercialization of Thymosin beta 4, a 43-amino acid peptide (T(beta)4). The Company is concentrating its efforts on the use of T(beta)4 for the treatment of injured tissue and non-healing wounds to enable more rapid repair and/or tissue regeneration.
More from Market Guide: Expanded Business Description

Financial Summary
RegeneRx Biopharmaceuticals Inc. is a pharmaceutical research and development company focusing on the development of products to treat a variety of human diseases. For the six months ended 6/30/01, the Company reported no revenues. Net loss before extraordinary item totalled $71 thousand vs. income of $458 thousand. Revenues reflect the the lack of any products. Loss reflects a decrease in realized gains on the sale of investments.
More from Market Guide: Significant Developments

Officers
FY2000 Pay

Allan Goldstein, 63
Chairman, Pres, CEO
$27K
Albert Rosenfeld, 79
Treasurer, Sec., Director
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:RGRX.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 25-Apr-2001
$0.03 
Recent Price$0.42 
52-Week High
on 27-June-2001
$0.73 
Beta-11.18 
Daily Volume (3-month avg)36.1K
Daily Volume (10-day avg)24.0K
Stock Performance
52-Week Change+366.7%
52-Week Change
relative to S&P500
+526.1%
Share-Related Items
Market Capitalization$8.18M
Shares Outstanding19.5M
Float9.50M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.01 
Earnings (ttm)-$0.01 
Earnings (mrq)-$0.01 
SalesN/A 
Cash (mrq)$0.01 
Valuation Ratios
Price/Book (mrq)82.63 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)$0 
EBITDA (ttm)-$531.0K
Income available to common (ttm)-$270.0K
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-38.37%
Return on Equity (ttm)-55.65%
Financial Strength
Current Ratio (mrq)1.46 
Debt/Equity (mrq)0 
Total Cash (mrq)$288.0K
Short Interest
As of 8-Sep-1994
Shares Short35.0K
Percent of Float0.5%
Shares Short
(Prior Month)
480.0K
Short Ratio0.58 
Daily Volume60.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.